| 摘要 |
<p>The use of L-carnitine and its alkanoyl derivatives is described, optionally in the form of a pharmaceutically acceptable salt, in the preparation of a medicament which is useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy.</p> |
